Asia-Pacific is estimated to grow at the CAGR of 8.1% during the forecast period and is expected to reach around $8.5 billion in 2025. The developing economies of Asia-Pacific, especially China, Japan, and India are investing significantly in the development of innovative therapeutic and medical devices. For instance, Sonova Group in China had launched international training institute in Jiangsu province in 2017 which provide both theory and practical experience for hearing care staff. In April 2016, the company has successfully received the approval from the Indian government, Ministry of Corporate Affairs in the Central Registration Center for the establishment of a subsidiary of Lepu Medical in India. This expansion will help the company to expand its geographical footprints in Asia-Pacific and better serve and cater to the demand of its customers.
Also, the presence of various subsidiaries of major market players in Asia-Pacific region is again estimated to boost the market growth. For instance, Hearing Retail Group Pty. Limited, Sonova Australia Pty Limited, Sonova (Shanghai) Company, Limited., Sonova Hearing (Suzhou) Company, Limited, Sonova Japan Company, Limited, and Triton Hearing Limited are the subsidiaries of Sonova group operating in Asia-Pacific region.
Moreover, increasing incidences of several health disorders such as spinal cord injuries, epilepsy, and other disorders are contributing to the growth of electroceuticals market in Asia-Pacific region. As per the estimation of the WHO, the incidence of Epilepsy is considerably high in emerging economies such as China and India. According to Epilepsia, the Official Journal of the International League Against Epilepsy, in 2017, out of the around 4 billion people living in Asia-Pacific region, about 23 million people had epilepsy.
Further, a large count of patients having epilepsy are anticipated to drive the growth of electroceuticals market as electroceuticals can prove to be better option for treatment of the disease. Besides, the healthcare systems in Asia-Pacific region are improving significantly in terms of healthcare expenditure by individual and government along with rising insurance penetration which are expected to contribute significantly to the electroceutical market in the region.
The market study of the Asia-Pacific Electroceuticals market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.
Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.
Secondary Sources Include
- Financial reports of companies involved in the market.
- Whitepapers, research-papers, and news blogs.
- Company websites and their product catalog.
The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
1. Asia-Pacific Electroceuticals Market Research and Analysis by Product
2. Asia-Pacific Electroceuticals Market Research and Analysis by End-users
The Report Covers
- Comprehensive research methodology of the Asia-Pacific Electroceuticals market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Asia-Pacific Electroceuticals market.
- Insights about market determinants which are stimulating the Asia-Pacific Electroceuticals market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Table of Contents
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.3. Rules & Regulations
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
5.1.1. Cardioverter Defibrillators and Cardiac Pacemaker
5.1.2. Deep Brain Stimulators
184.108.40.206. Parkinson’s Disease
5.1.3. Spinal Cord Stimulators
220.127.116.11. Failed Back Syndrome
5.1.4. Vagus Nerve Stimulators
5.1.5. Cochlear Implants
18.104.22.168. Sensorineural Hearing Loss
5.1.6. Others (Sacral Nerve Stimulators, Transcutaneous Electrical Nerve Stimulators)
22.214.171.124. Urinary Incontinence
126.96.36.199. Treatment-Resistant Depression
5.2. Asia-Pacific Electroceuticals Market by End-Users
5.2.1. Hospitals and Clinics
5.2.2. Research Institutes
6.4. Rest of Asia-Pacific
7.2. Advanced Bionics AG
7.3. Boston Scientific Corp.
7.4. Cochlear Ltd.
7.5. Demant A/S
7.6. Edwards Lifesciences Corp.
7.7. Getinge AB
7.8. GlaxoSmithKline PLC
7.9. Medtronic PLC
7.10. Sonova Holding AG
A selection of companies mentioned in this report includes:
- Abbott Laboratories Inc.
- Advanced Bionics AG
- Boston Scientific Corp.
- Cochlear Ltd.
- Demant A/S
- Edwards Lifesciences Corp.
- Getinge AB
- GlaxoSmithKline PLC
- Medtronic PLC
- Sonova Holding AG